Literature DB >> 12709002

Melanocyte-keratinocyte cell transplantation for stable vitiligo.

Sanjeev V Mulekar1.   

Abstract

BACKGROUND: Vitiligo is a common disorder with a worldwide prevalence of 1-2%. In India the psychological and social impact of the disease is significant and is detrimental to patients.
OBJECTIVE: To evaluate the usefulness of epidermal cell transplantation in the treatment of vitiligo.
METHODS: A simpler and modified method based on that of Olsson and Juhlin has been used. It utilizes a shave biopsy skin sample of up to one-tenth the size of the recipient area. The skin sample is incubated, the cells mechanically separated using trypsin EDTA solution, and then centrifuged to prepare a suspension. The cell suspension is then applied to the derm-abraded depigmented skin area and collagen dressing is applied to keep it in place.
RESULTS: One hundred and twenty-two patients with generalized vitiligo, 43 with segmental and 19 with focal vitiligo were treated and observed for a period of 1 year. In the generalized vitiligo group 65 (53%) showed excellent pigmentation, 10 (8%) showed good pigmentation, 11 (9%) showed fair pigmentation and 28 (23%) patients showed poor pigmentation. Eight (7%) patients did not follow up. Thirty-six (84%), five (12%) and two (4%) patients showed excellent, good and poor pigmentation, respectively, in the segmental vitiligo group. Thirteen (69%) and five (26%) patients showed excellent and poor results, respectively, in the focal vitiligo group. One (5%) patient did not appear for follow up. Recurrence was observed in 15 patents.
CONCLUSION: This surgical treatment gives its best results in segmental and focal vitiligo, even with large affected areas, and in at least 50% of patients with generalized vitiligo, thus improving their appearance.

Entities:  

Mesh:

Year:  2003        PMID: 12709002     DOI: 10.1046/j.1365-4362.2003.01628.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  11 in total

1.  Evaluation of Repigmentation with Cultured Melanocyte Transplantation (CMT) Compared with Non-Cultured Epidermal Cell Transplantation in Vitiligo at 12th Week Reveals Better Repigmentation with CMT.

Authors:  Gunjan Verma; Suraj R Varkhande; Hemanta K Kar; Rajni Rani
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

2.  Autologous Non-cultured Basal Cell-Enriched Epidermal Cell Suspension Transplantation in Vitiligo: Indian Experience.

Authors:  Munish Paul
Journal:  J Cutan Aesthet Surg       Date:  2011-01

3.  A Review of Non-cultured Epidermal Cellular Grafting in Vitiligo.

Authors:  Nanja van Geel; Boon Kee Goh; Elien Wallaeys; Stefanie De Keyser; Jo Lambert
Journal:  J Cutan Aesthet Surg       Date:  2011-01

4.  Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo.

Authors:  Mei-Cai Zhu; Hong-Yu Ma; Zhi Zhan; Cheng-Gang Liu; Wei Luo; Guang Zhao
Journal:  Exp Ther Med       Date:  2016-12-02       Impact factor: 2.447

5.  Treatment Strategies for Hypopigmentation in the Context of Burn Hypertrophic Scars.

Authors:  Bonnie C Carney; Jacqueline P McKesey; Dean S Rosenthal; Jeffrey W Shupp
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-01-18

6.  High correlation between skin color based on CIELAB color space, epidermal melanocyte ratio, and melanocyte melanin content.

Authors:  Wen-Shyan Huang; Yi-Wen Wang; Kun-Che Hung; Pai-Shan Hsieh; Keng-Yen Fu; Lien-Guo Dai; Nien-Hsien Liou; Kuo-Hsing Ma; Jiang-Chuan Liu; Niann-Tzyy Dai
Journal:  PeerJ       Date:  2018-05-24       Impact factor: 2.984

Review 7.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

8.  Non-cultured melanocyte transfer in the management of stable vitiligo.

Authors:  Birinder Singh Gill; Manmohan Singh Brar; Neha Chaudhary; Avneet Randhawa
Journal:  J Family Med Prim Care       Date:  2019-09-30

9.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.

Authors:  V S Narayan; L L C van den Bol; N van Geel; M W Bekkenk; R M Luiten; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-12       Impact factor: 6.166

10.  Outcome of Repeated Use of Donor Site for Noncultured Epidermal Cellular Grafting in Stable Vitiligo: A Retrospective Study.

Authors:  Vasanop Vachiramon; Korn Triyangkulsri; Duangporn Saengwimol; Kumutnart Chanprapaph
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.